Justyna Kelly promoted to COO, Dr. Robin Hallett promoted to VP, Discovery and Translational Sciences, Dr. Sherin Al-Safadi to join…
Sensus to Bring FDA-cleared Non-invasive Drug-delivery System and Treatment Alternative to Needles to Dermatologists Beginning [Immediately/Date]BOCA RATON, Fla, Dec. 01,…
Data suggest potential therapeutic role for nomacopan in exacerbations in severe lung conditions such as COPD and COVID pneumoniaNEW YORK…
SCHEME OF ARRANGEMENT EFFECTIVE LONDON, Dec. 01, 2021 (GLOBE NEWSWIRE) -- ACCUSTEM UK is pleased to announce that, further to…
Cannabis at Holiday Celebrations...the New Stocking Stuffer? Poll Finds 91% of Cannabis Consumers in Adult-Use States Plan to Consume the…
-- Pasithea Clinics commences in-home IV ketamine infusion therapy in Florida and Nevada -- -- Treatments conducted by board-certified medical…
NOVATO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development…
Purchase expected to give Vaxart greater control over manufacturing schedulesSOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) -- Vaxart,…
Data demonstrates the strength of Werewolf’s innovative therapeutic approach across multiple conditionally activated pipeline programsCAMBRIDGE, Mass., Dec. 01, 2021 (GLOBE…
-DISSOLVE program on track with 12-month study fully enrolled--DISSOLVE II on track for full enrollment in early 2022--Top-line data from…